Skip to content

Drug interactions

Encorafenib + Temsirolimus

Severity: Moderate

Encorafenib and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib both inhibits and induces CYP3A4, so temsirolimus exposure may increase or decrease unpredictably. This could lead to either toxicity or reduced efficacy.

What this interaction means in plain words

Encorafenib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Encorafenib belongs to Oncology; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Mixed CYP3A4 inhibition and induction by encorafenib altering temsirolimus metabolism.

What to do

Monitor for signs of temsirolimus toxicity and loss of response. Adjust the temsirolimus dose based on tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encorafenib with Temsirolimus?

MediHelp rates the interaction as moderate. Encorafenib and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib both inhibits and induces CYP3A4, so temsirolimus exposure may increase or decrease unpredictably. This could lead to either toxicity or reduced efficacy.

How serious is the interaction between Encorafenib and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of temsirolimus toxicity and loss of response. Adjust the temsirolimus dose based on tolerability.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in